MALIGNANT SOLID TUMOR
Clinical trials for MALIGNANT SOLID TUMOR explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT SOLID TUMOR trials appear
Sign up with your email to follow new studies for MALIGNANT SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo tested for Hard-to-Treat cancers
Disease control TerminatedThis study tested an experimental drug called ZL-1218, alone or with another cancer drug, in 34 adults with advanced solid tumors that had stopped responding to standard treatments. The main goals were to check the drug's safety, find the right dose, and see if it could shrink tu…
Matched conditions: MALIGNANT SOLID TUMOR
Phase: PHASE1 • Sponsor: Zai Lab (Hong Kong), Ltd. • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
New antibody combo shows promise in early cancer trial
Disease control TerminatedThis trial tested a new antibody drug, GEN1055, in adults with advanced solid tumors. It was given alone or with pembrolizumab (with or without chemotherapy) to see if it is safe and works against cancer. The study was stopped early, but the goal was to find the best dose and mea…
Matched conditions: MALIGNANT SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Genmab • Aim: Disease control
Last updated May 11, 2026 20:48 UTC
-
New cancer drug GEN1078 tested in small, Early-Stage trial
Disease control TerminatedThis trial tested a new drug, GEN1078, in 3 people with advanced solid tumors that had stopped responding to standard treatments. The main goals were to check for side effects and see how the body processes the drug. The study was stopped early, so results are limited.
Matched conditions: MALIGNANT SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Genmab • Aim: Disease control
Last updated May 07, 2026 18:42 UTC